Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 25, 2017 - Issue 2
Submit an article Journal homepage
168
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration

Aslihan UzunOrdu University, Training and Research Hospital, Department of Ophthalmology, Ordu, TurkeyCorrespondence[email protected]
, MD,
Fatime Nilufer YalcindagAnkara University, Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
, Prof,
Sibel DemirelAnkara University, Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
, MD,
Figen BatýoðluAnkara University, Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
, Prof &
Emin OzmertAnkara University, Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey
, Prof
Pages 229-232 | Received 02 Jun 2015, Accepted 12 Oct 2015, Published online: 30 Jan 2016

REFERENCES

  • Telander DG. Inflammation and age-related macular degeneration (AMD). Semin Ophthalmol. 2011;26:192–197.
  • Abouammoh M, Sharma S. Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2011;22:152–158.
  • Mitchell P. A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab. Curr Med Res Opin. 2011;27:1465–1475.
  • Kokotas H, Grigoriadou M, Petersen MB. Age-related macular degeneration: genetic and clinical findings. Clin Chem Lab Med. 2011;49:601–616.
  • Biswas P, Sengupta S, Choudhary R, et al. Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration. Indian J Ophthalmol. 2011;59:191–196.
  • Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am. 2006;19:361–372.
  • Georgopoulos M, Polak K, Prager F, et al. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol. 2009;93:457–462.
  • Bakri SJ, Larson TA, Edwards AO. Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2008;246:779–781.
  • Sato T, Emi K, Ikeda T, et al. Severe intraocular inflammation after intravitreal injection of bevacizumab. Ophthalmology. 2010;117:512–516.
  • Johnson D, Hollands H, Hollands S, et al. Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol. 2010;45:239–242.
  • Mozayan A, Farah S. Acute anterior uveitis following intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2013;44:25–27.
  • Chong DY, Anand R, Williams PD, et al. Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection. Retina. 2010;30:1432–1440.
  • Kiss C, Michels S, Prager F, et al. Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab. Retina. 2006;26:877–881.
  • Goldberg RA, Shah CP, Wiegand TW, et al. Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes. Am J Ophthalmol. 2014;158:733–737.
  • Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30:453–464.
  • El-Harazi SM, Ruiz RS, Feldman RM, et al. Quantitative assessment of aqueous flare: the effect of age and pupillary dilation. Ophthalmic Surg Lasers. 2002;33:379–382.
  • Brown DM, Michels M, Kaiser PK, et al; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57–65.
  • Bressler NM, Chang TS, Suner IJ, et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: Clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117:747–756.
  • Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology. 2005;112:1048–1053.
  • Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431.
  • Zhang XY, Guo XF, Zhang SD, et al. Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis. Int J Ophthalmol. 2014;7:355–364.
  • Yeniad B, Ayranci O, Tuncer S, et al. Assessment of anterior chamber inflammation after intravitreal bevacizumab injection in different ocular exudative diseases. Eur J Ophthalmol. 2011;21:156–161.
  • Blaha GR, Brooks NO, Mackel CE, et al. Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medications. Retina. 2015;35(3):577–581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.